These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 1661297

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Interaction of dichloromethylene diphosphonate and vitamin D on bone of thyroparathyroidectomized rats.
    Weisbrode SE, Capen CC, Pendley CB.
    Am J Pathol; 1977 Oct; 89(1):137-52. PubMed ID: 143891
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of alendronate treatment on the osteoclastogenic potential of bone marrow cells in mice.
    van Beek ER, Löwik CW, Papapoulos SE.
    Bone; 1997 Apr; 20(4):335-40. PubMed ID: 9108353
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.
    Carano A, Teitelbaum SL, Konsek JD, Schlesinger PH, Blair HC.
    J Clin Invest; 1990 Feb; 85(2):456-61. PubMed ID: 2105340
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone.
    Flanagan AM, Chambers TJ.
    Calcif Tissue Int; 1991 Dec; 49(6):407-15. PubMed ID: 1840176
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A histopathological investigation on the effects of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the mandible of rats.
    Kaynak D, Meffert R, Günhan M, Günhan O, Ozkaya O.
    J Periodontol; 2000 May; 71(5):790-6. PubMed ID: 10872961
    [Abstract] [Full Text] [Related]

  • 34. Comparative study of inhibitory effects by murine interferon gamma and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK).
    Tohkin M, Kakudo S, Kasai H, Arita H.
    Cancer Immunol Immunother; 1994 Sep; 39(3):155-60. PubMed ID: 7522963
    [Abstract] [Full Text] [Related]

  • 35. Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone.
    Flanagan AM, Chambers TJ.
    Bone Miner; 1989 Apr; 6(1):33-43. PubMed ID: 2526673
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of dose, sex, and age on the disposition of alendronate, a potent antiosteolytic bisphosphonate, in rats.
    Lin JH, Chen IW, Duggan DE.
    Drug Metab Dispos; 1992 Apr; 20(4):473-8. PubMed ID: 1356720
    [Abstract] [Full Text] [Related]

  • 38. Effect of alendronate (bisphosphonate) in animal models of hyperparathyroidism.
    Thompson DD, Seedor JG, Grasser W, Rosenblatt M, Rodan GA.
    Contrib Nephrol; 1991 Apr; 91():134-9. PubMed ID: 1800005
    [No Abstract] [Full Text] [Related]

  • 39. BM 21.0955, a potent new bisphosphonate to inhibit bone resorption.
    Mühlbauer RC, Bauss F, Schenk R, Janner M, Bosies E, Strein K, Fleisch H.
    J Bone Miner Res; 1991 Sep; 6(9):1003-11. PubMed ID: 1838661
    [Abstract] [Full Text] [Related]

  • 40. The effect of alendronate doped calcium phosphates on bone cells activity.
    Boanini E, Torricelli P, Gazzano M, Fini M, Bigi A.
    Bone; 2012 Nov; 51(5):944-52. PubMed ID: 22878156
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.